With a 2023 valuation of USD 6.84 Bn, the global Biopsy Devices Market is projected to develop to USD 20.04 Bn by 2031, demonstrating a CAGR of 14.51% during the 2024–2031 forecast window.
At its core, Biopsy Devices pertains to a surgical procedure that takes tissue from an organ to detect the presence or extent of disease, most commonly malignant and inflammatory conditions. Stakeholders across the healthcare landscape are growingly turning to these solutions to meet contemporary demands.
Growth is bolstered by a convergence of factors: rising awareness among end users, continuous product innovation, and the growing emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold pronounced shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and growing investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Biopsy Devices Market Snapshot
Chapter 4. Global Biopsy Devices Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Product, & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product:
5.2.1. Needle Biopsy Devices
5.2.1.1. Guidance Systems
5.2.1.2. Biopsy Consoles
5.2.1.3. Site Markers
5.2.1.4. Biopsy Guns
5.2.1.4.1. Automated Systems
5.2.1.4.2. Semi-Automated Systems
5.2.1.5. Needles
5.2.2. Skin Biopsy Devices
5.2.2.1. Punch Biopsy Instruments
5.2.2.2. Shave Biopsy Instruments
5.2.3. Consumables
5.2.3.1. Forceps
5.2.3.2. Trocars
5.2.3.3. Trays
5.2.3.4. Other Consumables
Chapter 6. Market Segmentation 2: By Biopsy Type Estimates & Trend Analysis
6.1. By Biopsy Type & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Biopsy Type:
6.2.1. Tissue Biopsy
6.2.1.1. Needle Biopsy
6.2.1.2. Skin Biopsy
6.2.1.3. Surgical Biopsy
6.2.2. Liquid Biopsy
Chapter 7. Market Segmentation 3: By Disease Type Estimates & Trend Analysis
7.1. By Disease Type & Market Share, 2019 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Disease Type:
7.2.1. Cancer
7.2.2. Infections
7.2.3. Autoimmune Disorders
7.2.4. Non-Cancerous Indications
7.2.5. Others
Chapter 8. Market Segmentation 4: By Anatomy Estimates & Trend Analysis
8.1. By Anatomy & Market Share, 2019 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Anatomy:
8.2.1. Breast
8.2.2. Lung
8.2.3. Bone
8.2.4. Liver
8.2.5. Uterus/Cervix/Ovary
8.2.6. Abdomen
8.2.7. Prostate
8.2.8. Cardiac
8.2.9. Skin
8.2.10. Others
Chapter 9. Market Segmentation 5: By Guidance Technique Estimates & Trend Analysis
9.1. By Guidance Technique & Market Share2019 2020 & 2031
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Guidance Technique:
9.2.1. X-Ray-Guided Biopsy
9.2.2. Ultrasound-Guided Biopsy
9.2.3. MRI-Guided Biopsy
9.2.4. CT-Guided Biopsy
Chapter 10. Biopsy Devices Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts By Product, 2024-2031
10.1.2. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts By Biopsy Type, 2024-2031
10.1.3. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts By Disease Type, 2024-2031
10.1.4. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts By Anatomy, 2024-2031
10.1.5. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts By Guidance Technique, 2024-2031
10.1.6. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts by country, 2024-2031
10.2. Europe
10.2.1. Europe Biopsy Devices Market revenue (US$ Million) By Product, 2024-2031
10.2.2. Europe Biopsy Devices Market revenue (US$ Million) By Biopsy Type, 2024-2031
10.2.3. Europe Biopsy Devices Market revenue (US$ Million) By Disease Type, 2024-2031
10.2.4. Europe Biopsy Devices Market revenue (US$ Million) By Anatomy, 2024-2031
10.2.5. Europe Biopsy Devices Market revenue (US$ Million) By Guidance Technique, 2024-2031
10.2.6. Europe Biopsy Devices Market revenue (US$ Million) by country, 2024-2031
10.3. Asia Pacific
10.3.1. Asia Pacific Biopsy Devices Market revenue (US$ Million) By Product, 2024-2031
10.3.2. Asia Pacific Biopsy Devices Market revenue (US$ Million) By Biopsy Type, 2024-2031
10.3.3. Asia Pacific Biopsy Devices Market revenue (US$ Million) By Disease Type, 2024-2031
10.3.4. Asia Pacific Biopsy Devices Market revenue (US$ Million) By Anatomy, 2024-2031
10.3.5. Asia Pacific Biopsy Devices Market revenue (US$ Million) By Guidance Technique, 2024-2031
10.3.6. Asia Pacific Biopsy Devices Market revenue (US$ Million) by country, 2024-2031
10.4. Latin America
10.4.1. Latin America Biopsy Devices Market revenue (US$ Million) By Product, 2024-2031
10.4.2. Latin America Biopsy Devices Market revenue (US$ Million) By Biopsy Type, 2024-2031
10.4.3. Latin America Biopsy Devices Market revenue (US$ Million) By Disease Type, 2024-2031
10.4.4. Latin America Biopsy Devices Market revenue (US$ Million) By Anatomy, 2024-2031
10.4.5. Latin America Biopsy Devices Market revenue (US$ Million) By Guidance Technique, 2024-2031
10.4.6. Latin America Biopsy Devices Market revenue (US$ Million) by country, 2024-2031
10.5. Middle East & Africa
10.5.1. Middle East & Africa Biopsy Devices Market revenue (US$ Million) By Product, 2024-2031
10.5.2. Middle East & Africa Biopsy Devices Market revenue (US$ Million) By Biopsy Type, 2024-2031
10.5.3. Middle East & Africa Biopsy Devices Market revenue (US$ Million) By Disease Type, 2024-2031
10.5.4. Middle East & Africa Biopsy Devices Market revenue (US$ Million) By Anatomy, 2024-2031
10.5.5. Middle East & Africa Biopsy Devices Market revenue (US$ Million) By Guidance Technique, 2024-2031
10.5.6. Middle East & Africa Biopsy Devices Market revenue (US$ Million) by country, 2024-2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Argon Medical Devices, Inc.
11.2.2. B. Braun SE
11.2.3. Becton, Dickinson and Company
11.2.4. Boston Scientific Corporation
11.2.5. Cardinal Health, Inc.
11.2.6. Cook Group Incorporated
11.2.7. Conmed Corporation
11.2.8. FUJIFILM Holdings Corporation
11.2.9. GE Healthcare
11.2.10. Inrad, Inc.
11.2.11. Medtronic plc
11.2.12. Olympus Corporation
11.2.13. Siemens Healthineers AG
11.2.14. Stryker Corporation
11.2.15. Zamar Care
11.2.16. Changzhou Jiuhong Medical Instrument Co., Ltd.
11.2.17. Kindly (KDL) Meditech
11.2.18. Ningbo Xinwell Medical Technology Co., LTD.
11.2.19. Shenzhen Manners Technology Co., Ltd.
11.2.20. Zhejiang Soudon Medical Technology Co., Ltd
11.2.21. Agilent Technologies, Inc.
11.2.22. BGI Group
11.2.23. Biocept, Inc.
11.2.24. Bio-Rad Laboratories, Inc.
11.2.25. Dxcover Limited
11.2.26. Elypta Limited
11.2.27. F. Hoffmann-La Roche Ltd
11.2.28. Illumina, Inc.
11.2.29. Micronoma
11.2.30. QIAGEN
11.2.31. Revvity, Inc.
11.2.32. Sysmex Corporation
11.2.33. Thermo Fisher Scientific Inc.